Moneycontrol PRO
ipca laboratories
Jump to
391 Results Found
  • Ipca Labs Q3 net profit up 24% to Rs 197.54cr Feb 12, 2020 03:00 PM IST

    Ipca Labs Q3 net profit up 24% to Rs 197.54cr

    The company had posted a net profit of Rs 159.11 crore for the corresponding period of previous fiscal, Ipca Laboratories said in a filing to the BSE.

  • Here's how Ipca Laboratories turned the tide and emerged as investor favourite Dec 26, 2019 08:38 PM IST

    Here's how Ipca Laboratories turned the tide and emerged as investor favourite

    Ipca, which was growing at frantic pace in the first half of this decade, lost steam in the middle due to regulatory woes.

  • Buy Ipca Laboratories target of Rs 1220: Sharekhan Nov 11, 2019 04:45 PM IST

    Buy Ipca Laboratories target of Rs 1220: Sharekhan

    Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1220 in its research report dated November 08, 2019.

  • Market Headstart: Nifty likely to open gap-up; Tata Elxsi, BEL top buys Aug 26, 2019 08:54 AM IST

    Market Headstart: Nifty likely to open gap-up; Tata Elxsi, BEL top buys

    Trends on SGX Nifty indicate a positive opening for the broader index in India, with 0.56 percent loss or 61 points. Nifty futures were trading around 10,890-level on the Singaporean Exchange.

  • USFDA issues three observations post inspection of Ipca Lab's Silvassa unit Aug 24, 2019 12:54 PM IST

    USFDA issues three observations post inspection of Ipca Lab's Silvassa unit

    The company said it is committed to address these observations promptly.

  • Buy Ipca Laboratories; target of Rs 1135: Sharekhan Aug 19, 2019 03:48 PM IST

    Buy Ipca Laboratories; target of Rs 1135: Sharekhan

    Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1135 in its research report dated August 14, 2019.

  • Accumulate Ipca Laboratories; target of Rs 1008: Prabhudas Lilladher Aug 19, 2019 01:56 PM IST

    Accumulate Ipca Laboratories; target of Rs 1008: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1008 in its research report dated August 14, 2019.

  • Buy Ipca Laboratories; target of Rs 1195: ICICI Direct Aug 16, 2019 01:26 PM IST

    Buy Ipca Laboratories; target of Rs 1195: ICICI Direct

    ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1195 in its research report dated August 14, 2019.

  • IPCA Laboratories Q1 PAT seen up 34.1% YoY to Rs. 87.9 cr: Prabhudas Lilladher Jul 12, 2019 05:08 PM IST

    IPCA Laboratories Q1 PAT seen up 34.1% YoY to Rs. 87.9 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 14 percent Y-o-Y (up 16.8 percent Q-o-Q) to Rs. 973.5 crore, according to Prabhudas Lilladher.

  • 'Nifty likely to make a move towards 12,000 in run-up to the Budget' Jul 03, 2019 09:33 AM IST

    'Nifty likely to make a move towards 12,000 in run-up to the Budget'

    The technical structure on the daily interval also suggests the upside momentum is likely to continue in the coming sessions

  • Ipca Labs Standalone March 2019 Net Sales at Rs 833.81 crore, up 6.52% Y-o-Y May 29, 2019 02:39 PM IST

    Ipca Labs Standalone March 2019 Net Sales at Rs 833.81 crore, up 6.52% Y-o-Y

  • Buy Ipca Laboratories; target of Rs 1135: Sharekhan May 02, 2019 03:09 PM IST

    Buy Ipca Laboratories; target of Rs 1135: Sharekhan

    Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1135 in its research report dated April 30, 2019.

  • Ipca Labs inks pact to acquire Ramdev Chemical for Rs 108.5 cr Apr 24, 2019 08:42 PM IST

    Ipca Labs inks pact to acquire Ramdev Chemical for Rs 108.5 cr

    The company has entered into a share purchase agreement (SPA) to acquire 100 per cent paid-up share capital of Ramdev Chemical Pvt Ltd (RCPL), Ipca Laboratories said in a regulatory filing.

  • IPCA Laboratories Q4 PAT seen up 106.1% YoY to Rs. 105.8 cr: Prabhudas Lilladher Apr 12, 2019 01:13 PM IST

    IPCA Laboratories Q4 PAT seen up 106.1% YoY to Rs. 105.8 cr: Prabhudas Lilladher

    Net Sales are expected to increase by 24.2 percent Y-o-Y (up 2.5 percent Q-o-Q) to Rs. 970.8 crore, according to Prabhudas Lilladher.

  • Buy Ipca Laboratories; target of Rs 900: ICICI Direct Feb 25, 2019 04:24 PM IST

    Buy Ipca Laboratories; target of Rs 900: ICICI Direct

    ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 900 in its research report dated February 13, 2019.

  • Nomura raises Ipca Labs price target on hope of strong earnings growth ahead Feb 18, 2019 09:02 AM IST

    Nomura raises Ipca Labs price target on hope of strong earnings growth ahead

    Japanese brokerage house Nomura has retained its buy call on Ipca Laboratories and raised price target to Rs 1,005 from Rs 915 apiece after revising earnings growth estimates upward.

  • Ipca Labs Q3 profit jumps 52% to Rs 160 cr on strong operating income Feb 12, 2019 03:27 PM IST

    Ipca Labs Q3 profit jumps 52% to Rs 160 cr on strong operating income

    Branded exports revenue grew by 41 percent and active pharmaceutical ingredient (API) exports increased 40 percent YoY.

  • Ipca Labs Standalone December 2018 Net Sales at Rs 947.59 crore, up 10.29% Y-o-Y Feb 12, 2019 02:47 PM IST

    Ipca Labs Standalone December 2018 Net Sales at Rs 947.59 crore, up 10.29% Y-o-Y

  • Buy Ipca Laboratories; target of Rs 829: Prabhudas Lilladher Nov 20, 2018 01:49 PM IST

    Buy Ipca Laboratories; target of Rs 829: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 829 in its research report dated November 15, 2018.

  • Nomura raises target price for Ipca Labs by 26% as earnings growth to remain robust Nov 19, 2018 10:31 AM IST

    Nomura raises target price for Ipca Labs by 26% as earnings growth to remain robust

    Nomura expects Ipca Labs to sustain 11-13 percent growth, and in exports & API, it expects 18 percent revenue CAGR over FY19-21.

  • Ipca Labs Standalone September 2018 Net Sales at Rs 997.82 crore, up 15.45% Y-o-Y Nov 14, 2018 01:38 PM IST

    Ipca Labs Standalone September 2018 Net Sales at Rs 997.82 crore, up 15.45% Y-o-Y

  • Ipca Labs gains 6% on USFDA exemption for two APIs Oct 30, 2018 02:21 PM IST

    Ipca Labs gains 6% on USFDA exemption for two APIs

    Ipca Labs' two active pharmaceutical ingredients (API) exempted from import alerts by US Food and Drug Administration are Furosemide & Chloroquine Phosphate (CQP).

  • Ipca Labs subsidiary acquires 80% stake in Bayshore Pharmaceuticals for $10.28 mn Oct 03, 2018 10:55 AM IST

    Ipca Labs subsidiary acquires 80% stake in Bayshore Pharmaceuticals for $10.28 mn

    The acquisition of the majority stake in Bayshore by Ipca Labs' wholly-owned subsidiary will enable the company to commercialise its registered generics drug products in the US market through this entity, Ipca Laboratories said in a regulatory filing.

  • Buy Ipca Laboratories; target of Rs 837: Prabhudas Lilladher Jun 08, 2018 04:32 PM IST

    Buy Ipca Laboratories; target of Rs 837: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 837 in its research report dated May 31, 2018.

  • IPCA Laboratories Q4 PAT seen up 209.3% YoY to Rs. 83.8 cr: Edelweiss Apr 16, 2018 06:13 PM IST

    IPCA Laboratories Q4 PAT seen up 209.3% YoY to Rs. 83.8 cr: Edelweiss

    Net Sales are expected to increase by 19.4 percent Y-o-Y (down 7.5 percent Q-o-Q) to Rs. 795.1 crore, according to Edelweiss.

Sections
ISO 27001 - BSI Assurance Mark